pretransfusiemonitoring

Pretransfusion monitoring refers to the set of assessment and verification activities performed before administering blood or blood components to a patient. The aim is to ensure safety, compatibility, and clinical appropriateness of the transfusion, while identifying risk factors for adverse reactions.

Key elements include patient identification and informed consent, review of medical history for prior transfusion reactions, allergies, and current medications or conditions that may affect transfusion risk. Baseline clinical assessments, such as vital signs and the assessment of volume status and symptoms of anemia or hypoxia, help determine urgency and suitability. Laboratory testing typically involves ABO and Rh typing and an antibody screen to detect clinically significant alloantibodies. A crossmatch with compatible donor units is performed when required, to confirm compatibility between the patient’s serum and the prospective blood products. Specimen labeling and record-keeping are essential components of the process.

A two-person verification is commonly used to confirm correct patient identity, correct product type, unit number, expiration date, and matching compatibility labels before administration. Any abnormalities in test results, patient status, or product information should prompt a pause in the transfusion and re-evaluation, following local protocols.

Certain circumstances may influence pretransfusion monitoring, including pediatrics, obstetrics, immunized or alloimmunized patients, history of transfusion reactions, or the need for specialized products. Premedication with antipyretics or antihistamines is not routinely recommended and is considered only for specific indications.

Documentation and communication are integral, ensuring a clear record of testing results, compatibility decisions, and plans for monitoring during and after transfusion.